Why do treatment outcomes often differ between populations? Human Pangenome Project catalogs genomes of 47 people from around the world to help science understand health disparities

bmq xzrf cfa pn alq v
Credit: Darryl Leja/NHGRI

For years, researchers have called for a resource more inclusive of human diversity with which to diagnose diseases and guide medical treatments. Now scientists with the Human Pangenome Reference Consortium have made groundbreaking progress in characterizing the fraction of human DNA that varies between individuals. As they recently published in Nature, they’ve assembled genomic sequences of 47 people from around the world into a so-called pangenome in which more than 99 percent of each sequence is rendered with high accuracy.

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

The current 47-people pangenome is just a starting point, however. The HPRC’s ultimate goal is to produce high-quality, nearly error-free genomes from at least 350 individuals from diverse populations by mid-2024, a milestone that would make it possible to capture rare alleles that confer important adaptive traits. Tibetans, for example, have alleles related to oxygen use and UV light exposure that enable them to live at high altitudes.

A major challenge in collecting this data will be to gain trust from communities that have seen past abuses of biological data; for example, there are no samples in the current study from Native American nor Aboriginal peoples, who have long been disregarded or exploited by scientific studies.

This is an excerpt. Read the full article here

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-May-26-2026-07_51_21-AM-2
Viewpoint: There are more than 1,000 chemicals in a cup of coffee—including many substances that can cause cancer. Why isn’t it banned?
Screenshot 2026-05-29 at 2.47
Psychological inoculation: With a vaccine to prevent HIV on the horizon, misinformation is soaring. What can be done.
ChatGPT-Image-May-28-2026-02_12_17-PM
Can ‘Social Stress Indicators’ help contain social media misfluencers?
Screenshot-2026-04-30-at-11.33.46-AM
Anti-seed-oil to anti-vax pipeline: MAHA movement spreads to teen influencers
Screenshot-2026-04-14-at-11.11.06-AM
‘Turbo cancer’ or mRNA cancer cure? Strategies to counter misinformation
Screenshot-2026-05-29-at-1.23.52-PM
Viewpoint: Scientists recently revised downward the likelihood of catastrophic global warming. Reassured? You shouldn't be.
Screenshot 2025-07-30 at 10.48
Can gene editing eliminate Down syndrome? Scientists have done it in lab-grown cells
ChatGPT-Image-May-22-2026-10_56_42-AM-2
‘It’s not super useful’: As wariness about AI grows, Trump proposes rollback of healthcare safeguards
ChatGPT Image May 28, 2026, 08_16_38 PM
Viewpoint: Why the EPA mismeasures cancer risk of chemicals and what should be done to fix it
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot-2026-05-29-at-12.17.58-PM
RFK, Jr.’s delusion: Anti-depressants are not harder to quit than heroin—but that does not mean tapering off is easy
Screenshot-2026-05-27-at-10.51.25-AM
Viewpoint: ‘Monsanto’ blues—Planned Netflix movie promises yet another round of anti-glyphosate disinformation
downsyndrome_compilation_MID_1
CRISPR breakthrough that can remove the chromosome responsible for Down syndrome raises ethical questions
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.